NASDAQ:CERN - Cerner Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$64.37 +1.94 (+3.11 %)
(As of 10/17/2018 03:45 AM ET)
Previous Close$62.43
Today's Range$62.57 - $64.60
52-Week Range$52.05 - $73.46
Volume1.35 million shs
Average Volume2.20 million shs
Market Capitalization$21.19 billion
P/E Ratio29.26
Dividend YieldN/A
Beta0.92
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. It also provides HealtheIntent platform, a cloud-based platform that enables organizations to aggregate, transform, and reconcile data across the continuum of care, as well as EHR agnostic platform, CareAware, that facilitates connectivity of health care devices to EHRs. In addition, the company offers a portfolio of clinical and financial health care information technology solutions, as well as departmental, connectivity, population health, and care coordination solutions; and various complementary services, including support, hosting, managed, implementation, and strategic consulting services. Further, it provides various services, such as implementation and training, remote hosting, operational management, revenue cycle, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs, and third party administrator services for employer-based health plans; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. Cerner Corporation was founded in 1979 and is headquartered in North Kansas City, Missouri.

Receive CERN News and Ratings via Email

Sign-up to receive the latest news and ratings for CERN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:CERN
CUSIP15678210
Phone816-221-1024

Debt

Debt-to-Equity Ratio0.09
Current Ratio2.85
Quick Ratio2.83

Price-To-Earnings

Trailing P/E Ratio29.26
Forward P/E Ratio28.23
P/E Growth2.04

Sales & Book Value

Annual Sales$5.14 billion
Price / Sales4.12
Cash Flow$3.9808 per share
Price / Cash16.17
Book Value$14.40 per share
Price / Book4.47

Profitability

EPS (Most Recent Fiscal Year)$2.20
Net Income$866.97 million
Net Margins16.06%
Return on Equity15.26%
Return on Assets11.34%

Miscellaneous

Employees26,000
Outstanding Shares329,000,000
Market Cap$21.19 billion

Cerner (NASDAQ:CERN) Frequently Asked Questions

What is Cerner's stock symbol?

Cerner trades on the NASDAQ under the ticker symbol "CERN."

How will Cerner's stock buyback program work?

Cerner declared that its board has authorized a share buyback plan on Sunday, June 4th 2017, which authorizes the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire up to 2.3% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its shares are undervalued.

How were Cerner's earnings last quarter?

Cerner Co. (NASDAQ:CERN) released its quarterly earnings data on Thursday, August, 2nd. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.60 by $0.02. The firm had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.33 billion. Cerner had a return on equity of 15.26% and a net margin of 16.06%. Cerner's revenue was up 5.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.61 EPS. View Cerner's Earnings History.

When is Cerner's next earnings date?

Cerner is scheduled to release their next quarterly earnings announcement on Thursday, October 25th 2018. View Earnings Estimates for Cerner.

What guidance has Cerner issued on next quarter's earnings?

Cerner issued an update on its FY18 earnings guidance on Thursday, August, 2nd. The company provided earnings per share (EPS) guidance of $2.45-2.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.50. The company issued revenue guidance of $5.325-5.450 billion, compared to the consensus revenue estimate of $5.37 billion.Cerner also updated its Q3 guidance to $0.62-0.64 EPS.

What price target have analysts set for CERN?

18 equities research analysts have issued twelve-month price objectives for Cerner's shares. Their predictions range from $64.65 to $80.00. On average, they anticipate Cerner's share price to reach $71.7607 in the next twelve months. This suggests a possible upside of 11.5% from the stock's current price. View Analyst Price Targets for Cerner.

What is the consensus analysts' recommendation for Cerner?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerner in the last year. There are currently 7 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cerner.

What are Wall Street analysts saying about Cerner stock?

Here are some recent quotes from research analysts about Cerner stock:
  • 1. According to Zacks Investment Research, "Cerner underperformed its industry in a year’s time. The company’s Subscription and Reimbursed travel revenues are declining. A significant drop in operating income and margin is worrisome. High long-term debt is another concern. Competition in the global MedTech space adds to the woes. However, Cerner saw consistent growth in its Electronic Health Record platform and Revenue Cycle Management solutions. Cerner Millennium and Cerner ITWorks continue to drive results. Growth in Licensed Software and Professional services is noteworthy. Cerner’s CommunityWorks organization continues to perform well in the small hospital market space. Solid international growth also raises hopes. Management is optimistic about solid booking contributions from Australia, Canada, Middle East and Europe in the second half of 2018. A positive guidance for 2018 is encouraging. In recent times, Cerner has seen a slew of developments." (10/8/2018)
  • 2. Cantor Fitzgerald analysts commented, "Our rating remains Overweight and our PT remains $80. Although some amount of investor skepticism regarding the company’s growth outlook continues to temper valuation levels, we do not share those concerns. Our long-term DCF model assumptions are mostly conservative, with high single-digit revenue growth and modest margin expansion. Capital spending should moderate in 2019. We think the shares offer a compelling risk/reward trade off (including the potential impact from the VA contract). Valuation Summary Cerner shares trade at a 25% discount to our DCF-based price target of $80 (including the VA contract)." (9/12/2018)
  • 3. Canaccord Genuity analysts commented, "We reiterate our BUY rating and raise our PT to $73. Not without noise on 4Q’17 and updated guidance, CERN continues to perform in new business wins. Bookings performance was stellar, up 62% y/y on large Works wins with solid growth across many product areas. The delayed Veterans Administration signing and some pre-revenue project investment will likely pressure margins near-term, but will be more than offset on the bottom-line from the tax reform benefit. We normally would be more critical on near-term margin compression; however, given bookings strength and benefits from tax reform, we recommend investors continue to own shares and add to positions. Key positive: Bookings grew 62% to $2.3B, outperforming us and cons. both at $1.8B. 1Q’18 bookings guidance straddled our estimate and con." (2/7/2018)

Who are some of Cerner's key competitors?

Who are Cerner's key executives?

Cerner's management team includes the folowing people:
  • Mr. Clifford W. Illig, Co-Founder & Vice Chairman (Age 67)
  • Mr. Zane M. Burke, Pres (Age 52)
  • Mr. Marc G. Naughton, Exec. VP & CFO (Age 63)
  • Mr. Michael R. Nill, Exec. VP & COO (Age 53)
  • Mr. Jeffrey A. Townsend, Exec. VP & Chief of Innovation (Age 54)

Who are Cerner's major shareholders?

Cerner's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Bank of Montreal Can (0.08%), Capital Investment Services of America Inc. (0.07%), DNB Asset Management AS (0.06%), Rockland Trust Co. (0.05%), North Growth Management Ltd. (0.04%) and Trust Department MB Financial Bank N A (0.03%). Company insiders that own Cerner stock include Clifford W Illig, David Brent Shafer, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, Randy D Sims, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner.

Which major investors are selling Cerner stock?

CERN stock was sold by a variety of institutional investors in the last quarter, including Bristol John W & Co. Inc. NY, Riverbridge Partners LLC, North Growth Management Ltd., Andra AP fonden, Rockland Trust Co., Pittenger & Anderson Inc., Webster Bank N. A. and Cape Cod Five Cents Savings Bank. Company insiders that have sold Cerner company stock in the last year include Clifford W Illig, David Brent Shafer, Denis A Cortese, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael R Battaglioli, William D Zollars and Zane M Burke. View Insider Buying and Selling for Cerner.

Which major investors are buying Cerner stock?

CERN stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, DNB Asset Management AS, Nisa Investment Advisors LLC, First Hawaiian Bank, We Are One Seven LLC, Forte Capital LLC ADV, Advisors Capital Management LLC and Raymond James Trust N.A.. View Insider Buying and Selling for Cerner.

How do I buy shares of Cerner?

Shares of CERN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerner's stock price today?

One share of CERN stock can currently be purchased for approximately $64.37.

How big of a company is Cerner?

Cerner has a market capitalization of $21.19 billion and generates $5.14 billion in revenue each year. The company earns $866.97 million in net income (profit) each year or $2.20 on an earnings per share basis. Cerner employs 26,000 workers across the globe.

What is Cerner's official website?

The official website for Cerner is http://www.cerner.com.

How can I contact Cerner?

Cerner's mailing address is 2800 ROCKCREEK PKWY W0162, NORTH KANSAS CITY MO, 64117. The company can be reached via phone at 816-221-1024 or via email at [email protected]


MarketBeat Community Rating for Cerner (NASDAQ CERN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  832 (Vote Outperform)
Underperform Votes:  508 (Vote Underperform)
Total Votes:  1,340
MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe CERN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel